Canada· CA-DIN-02266342
FLUMAZENIL INJECTION
A flumazenil product containing flumazenil, registered in Canada by FRESENIUS KABI CANADA LTD. The same ATC class is registered in 17 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Flumazenil is registered in 17 of 19 countries.
Countries holding a registration under ATC V03AB25 (flumazenil), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 9 of them publish a price we can compare per daily dose
Flumazenil · ATC V03AB25
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- FLUMAZENIL
- Manufacturer
- FRESENIUS KABI CANADA LTD
- Country
- Canada (CA)
- ATC code
- V03AB25
- ATC class
- Flumazenil
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
63 interactions on record for flumazenil.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Flumazenil · interactions on record
63 records
- 11 severe
- 16 moderate
- 3 minor
- 33 info
Most severe, free to view
- DoxepinD04AX01severe
- DesipramineN06AA01severe
- ImipramineN06AA02severe
- ClomipramineN06AA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Flumazenil in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesFlumazenilA-S Medication Solutions
- United KingdomAnexate 500micrograms/5ml solution for injection ampoulesRoche Products Ltd
- GermanyAnexateCheplapharm Arzneimittel Gmbh
- SpainANEXATE 0,5 mg/5 ml SOLUCION INYECTABLECheplapharm Arzneimittel Gmbh
- FinlandFlumazenil ActavisActavis Group PTC ehf
- SwitzerlandAnexate, InjektionslösungCheplapharm Schweiz GmbH
- CzechiaFLUMAZENIL PHARMASELECTPharmaselect International Beteiligungs GmbH, Vídeň
- NetherlandsAnexate, 0,5 mg/5 ml en 1,0 mg/ 10 ml oplossing voor injectieCHEPLAPHARM Arzneimittel GmbH
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Anexate, Flumazenil B. Braun
- Belgium · Anexate, Flumazenil B. Braun
- Czechia · Flumazenil Pharmaselect
- Germany · Anexate, Flumazenil B. Braun
- Denmark · Flumazenil Fresenius Kabi, Flumazenil Hameln
- Spain · Anexate, Flumazenil Altan
- Finland · Flumazenil B. Braun, Flumazenil Fresenius Kabi
- France · Flumazenil Hikma, Flumazenil Viatris
- United Kingdom (Northern Ireland) · Flumazenil Hameln Pharma, Flumazenil Hikma Farmacêutica (Portugal)
- Greece · Anexate®, Demoxate
- Croatia · Anexate, Flumazenil B.Braun
- Hungary · Anexate, Flumazenil Kabi
- Ireland · Anexate
- Iceland · Flumazenil B. Braun
- Italy · Anexate, Flumazenil B. Braun
- Luxembourg · Flumazenil B. Braun
- Netherlands · Anexate, Flumazenil B. Braun
- Norway · Flumazenil Fresenius Kabi, Flumazenil Hameln
- Poland · Flumazenil B. Braun, Flumazenil Kabi
- Portugal · Flumazenilo Fresenius Kabi, Flumazenilo Generis
- Romania · Anexate, Flumazenil Pharmaselect
- Sweden · Flumazenil Fresenius Kabi, Flumazenil Hameln
- Slovenia · Anexate
- Slovakia · Flumazenil Pharmaselect
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d3b7f8d6-3025-4035-9954-c8ffb6cf6436 GET /v1/drugs/d3b7f8d6-3025-4035-9954-c8ffb6cf6436?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02266342",
"form": "SOLUTION",
"class": "Human",
"routes": [
"INTRAVENOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "V03AB25",
"schedule": [
"Ethical"
],
"drug_code": "75176",
"strengths": [
"0.1 MG"
],
"ahfs_class": null,
"substances": [
"FLUMAZENIL"
],
"product_categorization": null
}See everything about flumazenil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.